Publication | Closed Access

Eplerenone inhibits the macrophage-to-myofibroblast transition in rats with UUO-induced type 4 cardiorenal syndrome through the MR/CTGF pathway

InflammationCardiomyopathyCardiorenal SyndromesCardiovascular DiseaseCell SignalingMedicineMr/ctgf PathwayEndothelial DysfunctionVascular BiologyPharmacologyCell BiologyAtherosclerosisUuo-induced Type 4Cardiorenal Syndrome